New Stock News | Zhong Yi Medical Hong Kong Stock IPO Prospectus Invalid

The Hong Kong Stock IPO application submitted by Wenzhen Traditional Chinese Medicine on July 29, 2025 will expire after 6 months on January 29, 2026, with Haitong INT'L as its sole sponsor at the time of submission. This is the second time the company's IPO application has expired. The prospectus shows that Wenzhen Traditional Chinese Medicine has established a comprehensive layout of traditional Chinese medicine businesses to meet customers' needs for disease treatment, health preservation, and learning and practicing traditional Chinese medicine. During the performance period, the company generated revenue through traditional Chinese medicine medical services, traditional Chinese life products (including various traditional Chinese health products and traditional Chinese knowledge products), and traditional Chinese brain subscription services. According to the Insight Consulting report, in terms of revenue from AI-assisted services, Wenzhen Traditional Chinese Medicine was the largest AI-assisted traditional Chinese medicine medical service provider in mainland China in 2023 and 2024, with market shares of 1.5% and 1.3% respectively. The AI-assisted traditional Chinese medicine medical services market as a secondary market accounted for 1.4% of the overall traditional Chinese medicine medical services market in mainland China in 2024.